Published in Exp Cell Res on August 02, 2006
Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity (2008) 4.37
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene (2010) 2.91
Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol (2013) 2.22
High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19
High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem (2010) 1.79
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis. PLoS One (2015) 1.43
High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal (2011) 1.27
Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells (2008) 1.26
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ (2013) 1.25
Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc Natl Acad Sci U S A (2014) 1.20
Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting. Dalton Trans (2009) 1.17
High-mobility group protein box-1 and its relevance to cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.16
Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Biochemistry (2011) 1.13
Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal (2012) 1.11
The high mobility group box: the ultimate utility player of a cell. Trends Biochem Sci (2012) 1.05
High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). J Biol Chem (2014) 1.03
Effect of starvation on transcriptomes of brain and liver in adult female zebrafish (Danio rerio). Physiol Genomics (2008) 1.01
Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res (2013) 1.01
The role of high mobility group box 1 in innate immunity. Yonsei Med J (2014) 1.00
Redox properties of the A-domain of the HMGB1 protein. FEBS Lett (2008) 1.00
Armed response: how dying cells influence T-cell functions. Immunol Rev (2011) 0.99
HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat. Histochem Cell Biol (2011) 0.99
Regulation of the autophagic bcl-2/beclin 1 interaction. Cells (2012) 0.98
HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ (2011) 0.96
Redox modulation of HMGB1-related signaling. Antioxid Redox Signal (2013) 0.94
Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ (2013) 0.93
Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLoS One (2012) 0.92
Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway. PLoS One (2009) 0.90
Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain. Brain Behav Immun (2014) 0.89
Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol (2013) 0.89
Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med (2015) 0.88
Oxidative stress-mediated HMGB1 biology. Front Physiol (2015) 0.87
High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int (2014) 0.85
Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition. PLoS One (2014) 0.83
The HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary Dysfunction. Antioxid Redox Signal (2015) 0.82
Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy. Am J Cancer Res (2015) 0.81
Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion. Mol Med (2015) 0.81
High mobility group box protein-1 in wound repair. Cells (2012) 0.80
High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer. Oxid Med Cell Longev (2015) 0.79
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking. J Leukoc Biol (2015) 0.79
Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium. Mol Med (2015) 0.79
Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1. PLoS One (2014) 0.79
HMGB1 is a therapeutic target for leukemia. Am J Blood Res (2012) 0.78
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis. Stem Cells Int (2016) 0.78
Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD). PLoS One (2014) 0.78
Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response. J Virol (2016) 0.76
Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther (2015) 0.76
Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation. Biochem Pharmacol (2015) 0.76
Development of 'Redox Arrays' for identifying novel glutathionylated proteins in the secretome. Sci Rep (2015) 0.76
Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment. Annu Rev Chem Biomol Eng (2016) 0.75
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics. J Vis Exp (2016) 0.75
Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization. Mol Immunol (2013) 0.75
Emerging role of HMGB1 in lung diseases: friend or foe. J Cell Mol Med (2016) 0.75
Histone H3 and TORC1 prevent organelle dysfunction and cell death by promoting nuclear retention of HMGB proteins. Epigenetics Chromatin (2016) 0.75
The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget (2017) 0.75
HMGB1 redox during sepsis. Redox Biol (2017) 0.75
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol (2002) 3.13
Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem (2003) 2.30
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci (2002) 2.03
Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J Biol Chem (2004) 2.00
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol (2013) 1.86
SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci (2007) 1.77
Removal of retained subfoveal perfluoro-n-octane liquid. Am J Ophthalmol (2004) 1.77
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 1.59
Aqueous humor dynamics: a review. Open Ophthalmol J (2010) 1.55
Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics (2008) 1.50
Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and Peptide adduction chemistry. J Org Chem (2003) 1.49
Adverse events after intravitreal triamcinolone in patients with and without uveitis. Ophthalmology (2007) 1.45
Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics (2009) 1.39
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem (2004) 1.37
Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci (2006) 1.32
Punctin, a novel ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J Biol Chem (2002) 1.31
Hydrogen production by Cyanobacteria. Microb Cell Fact (2005) 1.29
Cone structure in retinal degeneration associated with mutations in the peripherin/RDS gene. Invest Ophthalmol Vis Sci (2011) 1.24
Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol (2004) 1.24
Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics (2010) 1.22
Evidence that light modulates protein nitration in rat retina. Mol Cell Proteomics (2002) 1.22
Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse. Exp Eye Res (2005) 1.20
Intense light exposure changes the crystallin content in retina. Exp Eye Res (2003) 1.20
Physical and functional interaction of DNA methyltransferase 3A with Mbd3 and Brg1 in mouse lymphosarcoma cells. Cancer Res (2005) 1.17
Crystallin distribution in Bruch's membrane-choroid complex from AMD and age-matched donor eyes. Exp Eye Res (2005) 1.16
Enhancement of chaperone function of alpha-crystallin by methylglyoxal modification. Biochemistry (2003) 1.15
Interaction between the photoreceptor-specific tubby-like protein 1 and the neuronal-specific GTPase dynamin-1. Invest Ophthalmol Vis Sci (2007) 1.14
Bestrophin interacts physically and functionally with protein phosphatase 2A. J Biol Chem (2002) 1.13
A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.13
Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol (2010) 1.12
Clusterin is present in drusen in age-related macular degeneration. Exp Eye Res (2002) 1.10
Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol (2006) 1.09
Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Mol Cell Proteomics (2009) 1.08
Tubby-like protein 1 (TULP1) interacts with F-actin in photoreceptor cells. Invest Ophthalmol Vis Sci (2005) 1.08
Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts. Free Radic Biol Med (2009) 1.06
Protein database, human retinal pigment epithelium. Mol Cell Proteomics (2003) 1.05
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol (2006) 1.05
Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci (2007) 1.03
Disease-causing mutations in the cellular retinaldehyde binding protein tighten and abolish ligand interactions. J Biol Chem (2003) 1.03
Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res (2005) 1.03
Duplication and divergence of zebrafish CRALBP genes uncovers novel role for RPE- and Muller-CRALBP in cone vision. Invest Ophthalmol Vis Sci (2008) 1.03
Imiquimod as an antiangiogenic agent. J Drugs Dermatol (2005) 1.03
Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics (2009) 1.03
Cellular retinaldehyde-binding protein interacts with ERM-binding phosphoprotein 50 in retinal pigment epithelium. Invest Ophthalmol Vis Sci (2004) 1.03
Isolevuglandin-modified proteins, including elevated levels of inactive calpain-1, accumulate in glaucomatous trabecular meshwork. Biochemistry (2007) 1.02
Quantitative proteomics: TGFβ₂ signaling in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2011) 1.02
Reopening of previously closed macular holes after cataract extraction. Am J Ophthalmol (2007) 1.02
VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) (2009) 1.01
Retracted Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics (2007) 1.00
Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophthalmol Vis Sci (2006) 0.99
Strategies to recover proteins from ocular tissues for proteomics. Proteomics (2008) 0.98
Cochlin in the eye: functional implications. Prog Retin Eye Res (2007) 0.98
The role of therapeutic angiogenesis in tissue repair and regeneration. Adv Skin Wound Care (2005) 0.97
Cochlin, intraocular pressure regulation and mechanosensing. PLoS One (2012) 0.96
Protein s-glutathionylation in retinal pigment epithelium converts heat shock protein 70 to an active chaperone. Exp Eye Res (2004) 0.95
Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods. Invest Ophthalmol Vis Sci (2011) 0.95
Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics (2009) 0.95
Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs). Chem Res Toxicol (2014) 0.95
Surgical drainage of chronic serous retinal detachment associated with uveitis. Retina (2008) 0.95
Endophthalmitis after 25-gauge transconjunctival sutureless vitrectomy. Retina (2006) 0.94
Characterization of semenogelin proteins in the human retina. Exp Eye Res (2006) 0.94
Transient closure of a retinal capillary hemangioma with verteporfin photodynamic therapy. Retina (2005) 0.93
Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry (2005) 0.92
CEP biomarkers as potential tools for monitoring therapeutics. PLoS One (2013) 0.92
Appositional suprachoroidal hemorrhage: a case-control study. Am J Ophthalmol (2004) 0.91
Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery. Am J Ophthalmol (2012) 0.91
Proteomic characterization of isolated retinal pigment epithelium microvilli. Mol Cell Proteomics (2004) 0.89
COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments. Invest Ophthalmol Vis Sci (2009) 0.89
Glucose-modulated tyrosine nitration in beta cells: targets and consequences. Arch Biochem Biophys (2009) 0.89
Laser trabeculoplasty induces changes in the trabecular meshwork glycoproteome: a pilot study. J Proteome Res (2009) 0.89
Focus on molecules: cellular retinaldehyde-binding protein (CRALBP). Exp Eye Res (2005) 0.89
Genetic, age and light mediated effects on crystallin protein expression in the retina. Photochem Photobiol (2007) 0.88
Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolamines. Chem Res Toxicol (2006) 0.88
Identification of CRALBP ligand interactions by photoaffinity labeling, hydrogen/deuterium exchange, and structural modeling. J Biol Chem (2004) 0.88
Clathrin and adaptin accumulation in drusen, Bruch's membrane and choroid in AMD and non-AMD donor eyes. Exp Eye Res (2006) 0.87
Cochlin induced TREK-1 co-expression and annexin A2 secretion: role in trabecular meshwork cell elongation and motility. PLoS One (2011) 0.87
Support for a proposed retinoid-processing protein complex in apical retinal pigment epithelium. Exp Eye Res (2004) 0.87
Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells. Mol Vis (2012) 0.87
Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci (2013) 0.87
Coats' disease, megalopapilla and Cornelia de Lange syndrome. Ophthalmic Genet (2009) 0.87
Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE. Chem Res Toxicol (2008) 0.87
Age-related changes in the retinal pigment epithelium (RPE). PLoS One (2012) 0.87
Cochlin and glaucoma: a mini-review. Vis Neurosci (2005) 0.87
Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology (2007) 0.87
The retinal pigment epithelium apical microvilli and retinal function. Adv Exp Med Biol (2006) 0.87
Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocin-induced diabetic rats. Stroke (2011) 0.86
CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol (2007) 0.86
Potential for transcriptional upregulation of cochlin in glaucomatous trabecular meshwork: a combinatorial bioinformatic and biochemical analytical approach. Invest Ophthalmol Vis Sci (2008) 0.86
Evolutionarily conserved long intergenic non-coding RNAs in the eye. Hum Mol Genet (2013) 0.85
Proteomic analysis of climatic keratopathy droplets. Invest Ophthalmol Vis Sci (2008) 0.85
Proteomic method for identification of tyrosine-nitrated proteins. Methods Mol Biol (2004) 0.85